Materias dentro de su búsqueda.
Mostrando 541 - 560 Resultados de 3,356 Para Buscar '"Cos"', tiempo de consulta: 0.33s Limitar resultados
  1. 541
    por Anthon, Carl Thomas, Pène, Frédéric, Perner, Anders, Azoulay, Elie, Puxty, Kathryn, Van De Louw, Andry, Barratt-Due, Andreas, Chawla, Sanjay, Castro, Pedro, Póvoa, Pedro, Coelho, Luis, Metaxa, Victoria, Kochanek, Matthias, Liebregts, Tobias, Kander, Thomas, Hästbacka, Johanna, Andreasen, Jo Bønding, Péju, Edwige, Nielsen, Lene Bjerregaard, Hvas, Christine Lodberg, Dufranc, Etienne, Canet, Emmanuel, Lundqvist, Linda, Wright, Christopher John, Schmidt, Julien, Uhel, Fabrice, Ait-Oufella, Hafid, Krag, Mette, Cos Badia, Elisabet, Díaz-Lagares, Cándido, Menat, Sophie, Voiriot, Guillaume, Clausen, Niels Erikstrup, Lorentzen, Kristian, Kvåle, Reidar, Hildebrandt, Thomas, Holten, Aleksander Rygh, Strand, Kristian, Tzalavras, Asterios, Bestle, Morten Heiberg, Klepstad, Pål, Fernandez, Sara, Vimpere, Damien, Paulino, Carolina, Graça, Carina, Lueck, Catherina, Juhl, Christian Svendsen, Costa, Carolina, Bådstøløkken, Per Martin, Miranda, Teresa, Lêdo, Lia Susana Aires, Sousa Torres, Joao Carlos, Granholm, Anders, Møller, Morten Hylander, Russell, Lene
    Publicado 2023
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU)
  2. 542
    por Kapit, Wynn
    Publicado 1977
    “…COS ;…”
    Libro
    The anatomy coloring book /
  3. 543
    por Maier, J, Zhang, H, Shi, X, Xu, Z, Hemperek, T, Garutti, E, Steinbrueck, G, Gomez, G, Maneuski, D, De aguiar francisco, O A, Fadeeva, N, Lipton, R J, Seidel, S C, Mohamed farook, M H, Phor, S, Popule, J, Nikolopoulos, K, Morozzi, A, Bellan, R, Lynn, D, Fadeyev, V, Lozano fantoba, M, Pellegrini, G, Bergauer, T, Lu, W, Yang, T, Fretwurst, E, Vila alvarez, I, Lopez virto, A M, Bhardwaj, A, Wu, Y, Marcisovsky, M, Gonella, L, Kyriakis, A, Carvalho akiba, K, Sopko, B, Kohout, Z, Solar, M, Casse, G, Lacasta llacer, C, Gsponer, A, Leroy, C, Moll, M, Dingfelder, J C, Schwandt, J, Wilson, F F, Muenstermann, D, Eremin, I, Kumar, T, Sun, Y, Sicho, P, Mikestikova, M, Nisius, R, Korolkov, I, Fano', L, Moscatelli, F, Staiano, A, Sopko, V, Meng, L, Zorzi, N, Otero ugobono, S, Manojlovic, M, Lounis, A, Collins, P, Tackmann, K, Dierlamm, A H, Fernandez garcia, M, Vilar cortabitarte, R, Ejopu, E, Mitina, D, Zaluzhnyy, A, Marone, M, Spiegel, L G, Cindro, V, Creanza, D M, Shivpuri, R K, Tuominen, E M, Koffas, T, Liu, Y, Parzefall, U, Hauser, M M, Sperlich, D, Ruzin, A, Kramer, U, Heintz, U, Pospisil, S, Slavicek, T, Dervan, P J, Zhang, C, Pintilie, I, Lastovicka medin, G, Jimenez ramos, M D C, Munoz chavero, F, Einsweiler, K F, Pernegger, H, Li, Y, Huegging, F G, Eckstein, D, Strebler, T, Gersabeck, M, Eremin, V, Rogozhkin, S, Apresyan, A, Zavrtanik, M, Kramberger, G, Hoeferkamp, M R, Sorenson, J D, Ranjan, K, Agrawal, N, Allport, P P, Kazas, I, Cartiglia, N, Makarenko, L, Ullan comes, M, Grosse-knetter, J, Bisanz, T, Marco hernandez, R, Mazorra de cos, J, Sieberer, P, Gaggl, P, Liu, P, Breugnon, P, Villani, E G, Buttar, C M, Fox, H, Golubev, A, Nikitin, A, Artuso, M, Mikuz, M, Kroll, J, Van beuzekom, M G, Starodumov, A, Luukka, P R, Iconomidou-fayard, L, Pilsl, B, Rohe, T V, Kilminster, B J, Wang, J, Krueger, H, Weingarten, J C, Hartmann, F, Barbero, M B, Chauveau, J, Eklund, L M, Parkes, C J, De capua, S, Verbitskaya, E, Mandic, I, Narayanan, E A, Grinstein, S, Bortoletto, D, Anagnostou, G, Bilei, G M, Sonneveld, J M, Szumlak, T, Anticic, T, Kodys, P, Wade, B M, Sadrozinski, H, Lauer, K, Marti i garcia, S, Waid, S E, Duarte campderros, J, Pangaud, P, Barrillon, P, Calderini, G, Munoz sanchez, F J, Shepelev, A, Gentry, A D, Kalliokoski, M K, Garcia argos, C, Mulvey, J F, Daskalakis, G, Oblakowska-mucha, A, Zareef, F, Brigljevic, V, Borghi, G, Gaubas, E, Quadt, A, Palomo pinto, F R
    Publicado 2002
    Enlace del recurso
    Development of Radiation Hard Semiconductor Devices for Very High Luminosity Colliders
  4. 544
    por Monteverdi, Claudio, 1567-1643
    Publicado 1986
    Tabla de Contenidos:
    Partituras Libro
    Madrigals, books IV and V /
  5. 545
    por Karadeniz, Fatih
    Publicado 2023
    “…Chitosan oligomers (COS) are polysaccharides obtained by the hydrolyzation of chitosan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In Vitro Anti-HIV-1 Activity of Chitosan Oligomers N-Conjugated with Asparagine and Glutamine
  6. 546
    “…One of the ways to standardize measurement is through development and use of core outcome sets (COS). There is limited involvement of low- and middle-income country (LMIC) stakeholders in COS development and use. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Awareness and experiences on core outcome set development and use amongst stakeholders from low- and middle- income countries: An online survey
  7. 547
    Publicado 1987
    “…Because cone outer segments (COS) are now known to be continually renewed, I reexamined COS morphogenesis in retinas of Xenopus tadpoles (prepared by standard histologic techniques and viewed by light and electron microscopy) to clarify how COS incorporate new membrane. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Cone outer segment morphogenesis: taper change and distal invaginations
  8. 548
    “…Objective: This study is to evaluate the anti-obese effects of glucosamine (GLC) and chitosan oligosaccharide (COS) on high-fat diet-induced obese rats. Methods: The rats were randomly divided into twelve groups: a normal diet group (NF), a high-fat diet group (HF), Orlistat group, GLC high-, middle-, and low-dose groups (GLC-H, GLC-M, GLC-L), COS1 (COS, number-average molecular weight ≤1000) high-, middle-, and low-dose groups (COS1-H, COS1-M, COS1-L), and COS2 (COS, number-average molecular weight ≤3000) high-, middle-, and low-dose groups (COS2-H, COS2-M, COS2-L). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats
  9. 549
    “…OBJECTIVES: The aim of the study was to evaluate citation analysis as an approach to measuring core outcome set (COS) uptake, by assessing whether the number of citations for a COS report could be used as a surrogate measure of uptake of the COS by clinical trialists. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Citation analysis did not provide a reliable assessment of core outcome set uptake
  10. 550
    “…Costunolide (COS) is a sesquiterpene lactone with anticancer properties. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
  11. 551
    “…However, this reduction in waste will only be realised through the uptake of COS by clinical trialists. Without uptake, the continued development of COS that are not implemented may add to waste in research. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessing the impact of a research funder’s recommendation to consider core outcome sets
  12. 552
    “…BACKGROUND: An annual update to a systematic review of core outcome sets (COS) for research ensures that the COMET database is up-to-date. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Choosing important health outcomes for comparative effectiveness research: 6(th) annual update to a systematic review of core outcome sets for research
  13. 553
    “…Examining what researchers involved in trials know and think about COS is essential to increase awareness and promote COS uptake. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A survey of knowledge, perceptions and use of core outcome sets among clinical trialists
  14. 554
    “…Herein, four chitooligosaccharide derivatives (COS-RA, COS-FA, COS-VA, COS-GA) were prepared by laccase-catalyzed chitooligosaccharide modification with rosmarinic acid (RA), ferulic acid (FA), gallic acid (GA), and vanillic acid (VA), and structures were characterized. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Spraying phenolic acid-modifiedchitooligosaccharide derivatives improves anthocyanin accumulation in grape
  15. 555
    “…This meta‐analysis aimed to evaluate the quality of controlled ovarian stimulation (COS) with co‐administration of gonadotropins and tamoxifen (COS with tamoxifen). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effectiveness of controlled ovarian stimulation with tamoxifen for patients with estrogen‐sensitive breast cancer: A systematic review and meta‐analysis
  16. 556
    “…The intestinal explants were incubated at 37 °C in culture medium for 4 h and exposed to the following treatments: (a) control (only culture medium), (b) DON (10 µM), (c) 25COS (0.025 mg·mL(−1) of COS); (d) 50COS (0.05 mg·mL(−1) of COS); (e) 25COS plus DON (25COS + DON); (f) 50COS plus DON (50COS + DON). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Low Levels of Chito-Oligosaccharides Are Not Effective in Reducing Deoxynivalenol Toxicity in Swine Jejunal Explants
  17. 557
    “…OBJECTIVE: This study aimed to investigate barriers and facilitators to core outcome set (COS) uptake in randomized controlled trials to inform the first steps in developing interventions to improve the uptake of COS. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In-depth qualitative interviews identified barriers and facilitators that influenced chief investigators’ use of core outcome sets in randomised controlled trials
  18. 558
    “…Chitosan oligosaccharides (COS) have shown positive effects on host gut health and influence on intestinal microbial community. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exploring Effects of Chitosan Oligosaccharides on Mice Gut Microbiota in in vitro Fermentation and Animal Model
  19. 559
    “…BACKGROUND: Clinical officers (COs), a mid-level cadre of health worker, are the backbone of healthcare provision in rural Kenya. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Job preferences among clinical officers in public sector facilities in rural Kenya: a discrete choice experiment
  20. 560
    “…However, there is limited information on the potential use of COS for sheep health and production. We supplemented COS via a loose lick to pregnant ewes maintained on pasture for 11 weeks with an estimated COS intake @100–600 mg/d/ewe from 5 weeks pre-lambing until lamb marking at ~4 weeks of age. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chitosan Oligosaccharide Supplementation Affects Immunity Markers in Ewes and Lambs during Gestation and Lactation
Herramientas de búsqueda: RSS